Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0002003059-26-000006

Options or other derivatives

  • Chief Commercial Officer acquired 1,134,500 shares (grant or award)
  • Chief Commercial Officer returned 1,134,500 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Smith Robert Paul JR Chief Commercial Officer 2026-03-19 Returned to the company · Stock Option (Right to Buy) −562,500 0 D
Smith Robert Paul JR Chief Commercial Officer 2026-03-19 Returned to the company · Stock Option (Right to Buy) −572,000 0 D
Smith Robert Paul JR Chief Commercial Officer 2026-03-19 Grant or award · Stock Option (Right to Buy) +562,500 562,500 D
Smith Robert Paul JR Chief Commercial Officer 2026-03-19 Grant or award · Stock Option (Right to Buy) +572,000 572,000 D
Loading xslF345X06/wk-form4_1774037994.xml…